OrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Clinical Trials as TopicClinical Trials, Phase I as TopicTreatment OutcomeClinical Trials, Phase III as TopicClinical Trials, Phase II as TopicNeoplasmsMaximum Tolerated DoseResearch DesignDrug Administration ScheduleDouble-Blind MethodDrug EvaluationAntineoplastic AgentsControlled Clinical Trials as TopicRandomized Controlled Trials as TopicDose-Response Relationship, DrugPatient SelectionAntineoplastic Combined Chemotherapy ProtocolsInfusions, IntravenousTime FactorsMulticenter Studies as TopicAdministration, OralPlacebosFollow-Up StudiesClinical Trials, Phase IV as TopicClinical Trials Data Monitoring CommitteesClinical ProtocolsProspective StudiesCombined Modality TherapyCoxiellaSingle-Blind MethodEvidence-Based MedicineArea Under CurveMetabolic Detoxication, Phase IEarly Termination of Clinical TrialsDrug Therapy, CombinationNauseaUnited StatesPeriodicals as TopicPilot ProjectsCongresses as TopicPaclitaxelFeasibility StudiesResearch SubjectsSample SizeSurvival AnalysisNeutropeniaQuality of LifeAntibodies, MonoclonalGuidelines as TopicLung NeoplasmsBiomedical ResearchEndpoint DeterminationQuestionnairesReview Literature as TopicDeoxycytidineBreast NeoplasmsInformed ConsentDrugs, InvestigationalSeverity of Illness IndexCamptothecinOutcome Assessment (Health Care)Patient Education as TopicRecurrenceAntineoplastic Agents, PhytogenicThrombocytopeniaSurvival RateMeta-Analysis as TopicDisease-Free SurvivalPractice Guidelines as TopicMedical OncologyDisease ProgressionFluorouracilCost-Benefit AnalysisAbstracting and Indexing as TopicRisk FactorsAntibodies, Monoclonal, HumanizedVomitingRisk AssessmentDrug-Related Side Effects and Adverse ReactionsReproducibility of ResultsPrognosisCisplatinTaxoidsPatient ParticipationNeoplasm StagingSafetyPatient ComplianceCancer VaccinesTextbooks as TopicDrug CombinationsResearch Support as TopicNontherapeutic Human ExperimentationFatigueTherapeutic Human ExperimentationMetabolic Clearance RateData Interpretation, StatisticalImmunotherapyCross-Over StudiesNeoplasm Recurrence, LocalNeoplasm Metastasis